Aún no tenemos la versión en español de la página que ha solicitado. Puede hacer clic en continuar para ver la página en inglés o cancelar para permanecer en esta página. Pronto estará disponible, gracias por su paciencia.

¡Hagamos correr la voz sobre la inmunoterapia! Haga clic para compartir esta página con su comunidad.

Fourth Annual #GivingTuesday a Record Success

01 de diciembre de 2015

Here’s to you—for kicking off this season with a gift for a good reason.

The Cancer Research Institute family extends a heartfelt THANK YOU to our supporters who helped make the fourth annual #GivingTuesday a monumental success at CRI. With your help, we raised over $127,000 to advance our programs—surpassing what came in last year on the day!

Because of you, the Cancer Research Institute remains at the forefront of efforts to harness the powers of our immune system to end cancer. We continue to expand research, enhance partnerships, and drive discovery in cancer immunotherapy to improve cancer treatments around the world.

In this last year alone, we've seen the FDA approvals of new immunotherapies for lung cancer, melanoma, brain cancer, leukemia, kidney cancer, and multiple myeloma. And it's only the beginning. These treatments couldn't come to fruition without your support of our scientists who are leading the charge in laboratories and clinics all over the world.

On behalf of those touched by your generosity, thank you.

Photo by Ben White on Unsplash.

Obtenga las últimas actualizaciones sobre inmunoterapia contra el cáncer

*Los resultados de la inmunoterapia pueden variar de un paciente a otro.

Top